People channel feed – Endpoints News

People channel feed

Walking the walk, Alnylam appoints former FDA head Margaret Hamburg to the board

7 years ago

Exclusive: At Hal Barron’s R&D group at GSK, consensus is out, leaders are in and watch out for an ‘intense drive’ to spur the late-stage pipeline

7 years ago

New Pfizer CEO Albert Bourla shakes up the top team that will now lead the pharma giant -- and there's a chief digital officer coming on board

7 years ago

Nimbus chief Don Nicholson hits the exit, handing top job over to Jeb Keiper

7 years ago

Forty Seven adds Nobel winner Jim Allison to a dream team of scientific advisers

7 years ago

Belldegrun and Chang groom their biotech unicorn Allogene for a monster $288M — or so — IPO

7 years ago

Cancer R&D stars Jim Allison, Tasuku Honjo awarded Nobel prize for immunotherapy discoveries

7 years ago

Ian Read taps his carefully groomed successor Albert Bourla as the next Pfizer CEO. What's his future look like?

7 years ago

A player in the bustling microbiome R&D arena promotes its CSO to the top post -- just ahead of a PhII NASH study

7 years ago

Merck board waves off a forced retirement for CEO Ken Frazier, happy to extend his reign

7 years ago

AstraZeneca CEO Pascal Soriot: 'I'm the lowest-paid CEO in the whole industry'

7 years ago

Fresh from the Novartis/Trump scandal, ex-CEO Joe Jimenez jumps on the board of uBiome — a biotech launching an R&D group

7 years ago

Clovis CEO Patrick Mahaffy settles up on SEC charges of lying about the roci data — and it won’t cost much

7 years ago

GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups

7 years ago

Another scientist pleads guilty for his role in a scheme to sell GSK's trade secrets in China

7 years ago

MSK's José Baselga steps off Bristol-Myers' board as the industry debates the controversy over industry ties

7 years ago

SEC charges that hedge fund manager (and priest) relied on false claims to promote a Ligand short attack

7 years ago

Scouting early-stage oncology plays, biopharma vets Detlev Biniszkiewicz, Scott Chappel make VC debut at MPM

7 years ago

Sanofi swaps top execs with Bayer, triggering a reorganization that puts China in the headlights

7 years ago

Joining the exodus at Gilead, CMO Andrew Cheng makes the switch to biotech CEO — triggering a cross-country move for Akero

7 years ago

The Broad wins another — perhaps final — battle in the war over Feng Zhang's CRISPR patents

7 years ago

SEC accuses biotech billionaire Phillip Frost of joining a 'pump-and-dump' scheme that netted $27M

7 years ago

A star cancer scientist failed to disclose industry payments over the years — does that matter so much?

7 years ago

Revolving door between industry and FDA continues to spin

7 years ago

First page Previous page 84 85 868788 89 90 Next page Last page